Skip to main content
. 2024 Aug 15;9(9):101545. doi: 10.1016/j.adro.2024.101545

Figure 3.

Figure 3

Combined dosimetric and clinicopathologic multivariable model for external lymphedema depicting increasing risk of external lymphedema with advanced (Adv) adenopathy status at diagnosis, more extensive lymph node (LN) dissections, and a radiation dose to the contralateral retropharyngeal (level VII) LN region V30 ≥50%.